{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:47:16Z","timestamp":1792090036401,"version":"4.4.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00520-026-11290-w","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:27:46Z","timestamp":1790846866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modulation of the gut microbiota by traditional Chinese medicine to attenuate chemotherapy-induced toxicity in gastric cancer: a review"],"prefix":"10.1007","volume":"34","author":[{"given":"Jialin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faxiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"11290_CR1","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ Lopez","year":"2023","unstructured":"Lopez MJ et al (2023) Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol 181:103841","journal-title":"Crit Rev Oncol Hematol"},{"key":"11290_CR2","volume":"44","author":"F He","year":"2024","unstructured":"He F et al (2024) Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050. Lancet Reg Health West Pac 44:101003","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"11290_CR3","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B et al (2024) Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 4(1):47\u201353","journal-title":"J Natl Cancer Cent"},{"issue":"5","key":"11290_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","volume":"23","author":"JA Ajani","year":"2025","unstructured":"Ajani JA et al (2025) Gastric cancer, version 2.2025, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 23(5):169\u2013191","journal-title":"J Natl Compr Canc Netw"},{"key":"11290_CR5","first-page":"175883592513464","volume":"17","author":"Y Chen","year":"2025","unstructured":"Chen Y et al (2025) Immune checkpoint inhibitors improve the efficacy of neoadjuvant chemotherapy in advanced gastric cancer: a retrospective cohort study. Ther Adv Med Oncol 17:17588359251346424","journal-title":"Ther Adv Med Oncol"},{"key":"11290_CR6","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y et al (2025) Immune checkpoint inhibitors plus chemotherapy in the first-line treatment of young unresectable gastric cancer patients: a multicentre real-world study. Front Oncol 15:1476402","journal-title":"Front Oncol"},{"issue":"5","key":"11290_CR7","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.21037\/jgo-2024-924","volume":"16","author":"AK Dip Borunda","year":"2025","unstructured":"Dip Borunda AK et al (2025) Impact of maintenance therapy with fluoropyrimidines in advanced esophageal-gastric adenocarcinoma: a retrospective study in Mexican population. J Gastrointest Oncol 16(5):1812\u20131819","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"11290_CR8","doi-asserted-by":"crossref","first-page":"952","DOI":"10.21037\/jgo-23-248","volume":"14","author":"F Tao","year":"2023","unstructured":"Tao F, Gong L, Dong Q (2023) Effect of negative emotions on patients with advanced gastric cancer receiving systemic chemotherapy: a prospective study. J Gastrointest Oncol 14(2):952\u2013962","journal-title":"J Gastrointest Oncol"},{"issue":"5","key":"11290_CR9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/annonc\/mdp464","volume":"21","author":"W Koizumi","year":"2010","unstructured":"Koizumi W et al (2010) Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study). Ann Oncol 21(5):1001\u20131005","journal-title":"Ann Oncol"},{"issue":"1","key":"11290_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s10120-015-0580-2","volume":"20","author":"S Yoon","year":"2017","unstructured":"Yoon S et al (2017) Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer. Gastric Cancer 20(1):182\u2013189","journal-title":"Gastric Cancer"},{"key":"11290_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040782","author":"S Ciernikova","year":"2021","unstructured":"Ciernikova S, Mego M, Chovanec M (2021) Exploring the potential role of the gut microbiome in chemotherapy-induced neurocognitive disorders and cardiovascular toxicity. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13040782","journal-title":"Cancers (Basel)"},{"key":"11290_CR12","doi-asserted-by":"crossref","unstructured":"Kunika, N. Frey and A.Y. Rangrez, Exploring the involvement of gut microbiota in cancer therapy-induced cardiotoxicity. Int J Mol Sci, 2023. 24(8).","DOI":"10.3390\/ijms24087261"},{"issue":"1","key":"11290_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5230\/jgc.2024.24.e4","volume":"24","author":"CH Park","year":"2024","unstructured":"Park CH (2024) Unveiling the gastrointestinal microbiome symphony: insights into post-gastric cancer treatment microbial patterns and potential therapeutic avenues. J Gastric Cancer 24(1):89\u201398","journal-title":"J Gastric Cancer"},{"issue":"6","key":"11290_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188990","volume":"1878","author":"S Ciernikova","year":"2023","unstructured":"Ciernikova S et al (2023) Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: an emerging trend in cancer patient care. Biochim Biophys Acta Rev Cancer 1878(6):188990","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"20","key":"11290_CR15","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.12998\/wjcc.v12.i20.4074","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024) Quality of life and survival analyses of breast cancer cases treated with integrated traditional Chinese and Western medicine. World J Clin Cases 12(20):4074\u20134081","journal-title":"World J Clin Cases"},{"issue":"3","key":"11290_CR16","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041291","volume":"104","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li S (2025) Extensive small cell lung cancer treated by integrated traditional Chinese and Western medicine: a case report. Medicine (Baltimore) 104(3):e41291","journal-title":"Medicine (Baltimore)"},{"key":"11290_CR17","volume":"203","author":"X Wei","year":"2024","unstructured":"Wei X et al (2024) The interactions between traditional Chinese medicine and gut microbiota in cancers: current status and future perspectives. Pharmacol Res 203:107148","journal-title":"Pharmacol Res"},{"key":"11290_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910255","author":"P Guevara-Ramirez","year":"2024","unstructured":"Guevara-Ramirez P et al (2024) Gut microbiota disruption in hematologic cancer therapy: molecular insights and implications for treatment efficacy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms251910255","journal-title":"Int J Mol Sci"},{"key":"11290_CR19","volume":"166","author":"B Huang","year":"2023","unstructured":"Huang B et al (2023) Babao Dan alleviates gut immune and microbiota disorders while impacting the TLR4\/MyD88\/NF-small ka, CyrillicB pathway to attenuate 5-Fluorouracil-induced intestinal injury. Biomed Pharmacother 166:115387","journal-title":"Biomed Pharmacother"},{"key":"11290_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jep.2016.02.035","volume":"183","author":"C Shi","year":"2016","unstructured":"Shi C et al (2016) Steamed root of Rehmannia glutinosa Libosch (Plantaginaceae) alleviates methotrexate-induced intestinal mucositis in rats. J Ethnopharmacol 183:143\u2013150","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"11290_CR21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13020-022-00667-8","volume":"17","author":"L Yin","year":"2022","unstructured":"Yin L et al (2022) Poria cocos polysaccharides exert prebiotic function to attenuate the adverse effects and improve the therapeutic outcome of 5-FU in Apc(Min\/+) mice. Chin Med 17(1):116","journal-title":"Chin Med"},{"issue":"1","key":"11290_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"F Wang","year":"2024","unstructured":"Wang F et al (2024) The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond) 44(1):127\u2013172","journal-title":"Cancer Commun (Lond)"},{"key":"11290_CR23","volume":"14","author":"Z Li","year":"2024","unstructured":"Li Z et al (2024) Dynamic changes in body composition during XELOX\/SOX chemotherapy in patients with gastric cancer. Front Oncol 14:1309681","journal-title":"Front Oncol"},{"issue":"3","key":"11290_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5414\/CP204479","volume":"62","author":"Y Gu","year":"2024","unstructured":"Gu Y et al (2024) Cost-effectiveness analysis of mecapegfilgrastim and recombinant human granulocyte stimulating factor for primary prophylaxis of chemotherapy-induced neutropenia in non-small cell lung cancer. Int J Clin Pharmacol Ther 62(3):115\u2013121","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"11290_CR25","doi-asserted-by":"publisher","first-page":"30992","DOI":"10.1038\/s41598-025-15360-7","volume":"15","author":"R Wang","year":"2025","unstructured":"Wang R et al (2025) The hidden costs of PEG-rhG-CSF in autologous stem cell transplantation for newly diagnosed multiple myeloma. Sci Rep 15(1):30992","journal-title":"Sci Rep"},{"issue":"6","key":"11290_CR26","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10147-024-02502-6","volume":"29","author":"M Ito","year":"2024","unstructured":"Ito M et al (2024) Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology. Int J Clin Oncol 29(6):689\u2013699","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"11290_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12094-025-03982-2","volume":"28","author":"AF Montes","year":"2026","unstructured":"Montes AF et al (2026) TTD expert consensus on emesis in gastric cancer: evidence-based strategies for prevention and treatment. Clin Transl Oncol 28(1):14\u201322","journal-title":"Clin Transl Oncol"},{"issue":"10","key":"11290_CR28","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.ejca.2015.03.024","volume":"51","author":"J Nishimura","year":"2015","unstructured":"Nishimura J et al (2015) Combination antiemetic therapy with aprepitant\/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial. Eur J Cancer 51(10):1274\u20131282","journal-title":"Eur J Cancer"},{"key":"11290_CR29","volume":"611","author":"Z Tao","year":"2024","unstructured":"Tao Z et al (2024) An emerging aspect of cancer neuroscience: a literature review on chemotherapy-induced peripheral neuropathy. Cancer Lett 611:217433","journal-title":"Cancer Lett"},{"issue":"2","key":"11290_CR30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.21037\/apm-24-154","volume":"14","author":"N Rahman","year":"2025","unstructured":"Rahman N, Sukumar J, Lustberg MB (2025) Chronic chemotherapy-induced peripheral neuropathy: living with neuropathy during and after cancer treatments. Ann Palliat Med 14(2):196\u2013216","journal-title":"Ann Palliat Med"},{"issue":"1","key":"11290_CR31","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2026.2655149","volume":"18","author":"YA Valentine","year":"2026","unstructured":"Valentine YA et al (2026) A systematic assessment of the short- and long-term effects of commonly used breast cancer chemotherapeutics on the gut microbiome\u2012blood\u2012brain axis of female mice. Gut Microbes 18(1):2655149","journal-title":"Gut Microbes"},{"key":"11290_CR32","volume":"517","author":"Y Xu","year":"2025","unstructured":"Xu Y et al (2025) Sorafenib induces intestinal toxicity by disturbing gut microbiota and activating the LPS\/TLR4\/NF-kappaB signaling pathway in mice. Toxicology 517:154220","journal-title":"Toxicology"},{"issue":"1","key":"11290_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00018-025-05632-w","volume":"82","author":"Y Yan","year":"2025","unstructured":"Yan Y, Satoh-Takayama N (2025) New perspectives on gastric disorders: the relationship between innate lymphoid cells and microbes in the stomach. Cell Mol Life Sci 82(1):113","journal-title":"Cell Mol Life Sci"},{"key":"11290_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-025-04704-y","author":"S Xu","year":"2026","unstructured":"Xu S et al (2026) Longitudinal analysis of postoperative chemotherapy on oral-gut microbiota in patients with advanced gastric cancer. BMC Microbiol. https:\/\/doi.org\/10.1186\/s12866-025-04704-y","journal-title":"BMC Microbiol"},{"issue":"28","key":"11290_CR35","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1038\/s41388-022-02377-9","volume":"41","author":"C Liu","year":"2022","unstructured":"Liu C et al (2022) Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis. Oncogene 41(28):3599\u20133610","journal-title":"Oncogene"},{"key":"11290_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010055","author":"M He","year":"2025","unstructured":"He M et al (2025) Advances in understanding the impact of human gut microbiota on chemotherapy-induced neutropenia. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines14010055","journal-title":"Biomedicines"},{"key":"11290_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14092982","author":"IG Dumitru","year":"2025","unstructured":"Dumitru IG et al (2025) A literature review on the impact of the gut microbiome on cancer treatment efficacy, disease evolution and toxicity: the implications for hematological malignancies. J Clin Med. https:\/\/doi.org\/10.3390\/jcm14092982","journal-title":"J Clin Med"},{"issue":"8","key":"11290_CR38","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/CS20220777","volume":"137","author":"W Chancharoenthana","year":"2023","unstructured":"Chancharoenthana W et al (2023) The leaky gut and the gut microbiome in sepsis - targets in research and treatment. Clin Sci (Lond) 137(8):645\u2013662","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"11290_CR39","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2240050","volume":"15","author":"A Nogal","year":"2023","unstructured":"Nogal A et al (2023) Genetic and gut microbiome determinants of SCFA circulating and fecal levels, postprandial responses and links to chronic and acute inflammation. Gut Microbes 15(1):2240050","journal-title":"Gut Microbes"},{"issue":"1","key":"11290_CR40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12964-025-02149-4","volume":"23","author":"R Luo","year":"2025","unstructured":"Luo R et al (2025) An examination of the LPS-TLR4 immune response through the analysis of molecular structures and protein-protein interactions. Cell Commun Signal 23(1):142","journal-title":"Cell Commun Signal"},{"issue":"10","key":"11290_CR41","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1128\/IAI.71.10.6058-6062.2003","volume":"71","author":"A Lembo","year":"2003","unstructured":"Lembo A et al (2003) Differential contribution of Toll-like receptors 4 and 2 to the cytokine response to Salmonella enterica serovar Typhimurium and Staphylococcus aureus in mice. Infect Immun 71(10):6058\u20136062","journal-title":"Infect Immun"},{"key":"11290_CR42","doi-asserted-by":"crossref","unstructured":"Wei, L., et al., Mahonia bealei (Fort.) Carr. leaf extract modulates the TLR2\/MyD88\/NF-kappaB signaling pathway to inhibit PGN-induced inflammation in RAW264.7 cells. J Ethnopharmacol, 2025. 344: p. 119510.","DOI":"10.1016\/j.jep.2025.119510"},{"issue":"1","key":"11290_CR43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41419-024-06473-4","volume":"15","author":"Z Cheng","year":"2024","unstructured":"Cheng Z et al (2024) HECTD3 inhibits NLRP3 inflammasome assembly and activation by blocking NLRP3-NEK7 interaction. Cell Death Dis 15(1):86","journal-title":"Cell Death Dis"},{"issue":"5","key":"11290_CR44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S et al (2021) An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol 18(5):1141\u20131160","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"11290_CR45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2026.101725","volume":"20","author":"J Shou","year":"2026","unstructured":"Shou J, Fu T (2026) Purinergic signaling at the crossroads of inflammation, microbiota, and intestinal fibrosis. Cell Mol Gastroenterol Hepatol 20(6):101725","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"11290_CR46","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Munoz-Planillo","year":"2013","unstructured":"Munoz-Planillo R et al (2013) K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38(6):1142\u20131153","journal-title":"Immunity"},{"key":"11290_CR47","doi-asserted-by":"crossref","unstructured":"Xu, J., et al., NEK7 phosphorylation amplifies NLRP3 inflammasome activation downstream of potassium efflux and gasdermin D. Sci Immunol, 2025. 10(103): p. eadl2993.","DOI":"10.1126\/sciimmunol.adl2993"},{"key":"11290_CR48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1233680","volume":"14","author":"M Krantz","year":"2023","unstructured":"Krantz M et al (2023) A detailed molecular network map and model of the NLRP3 inflammasome. Front Immunol 14:1233680","journal-title":"Front Immunol"},{"issue":"3","key":"11290_CR49","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s12276-026-01656-9","volume":"58","author":"HJ Shin","year":"2026","unstructured":"Shin HJ et al (2026) Molecular mechanisms of NLRP3 inflammasome activation. Exp Mol Med 58(3):650\u2013663","journal-title":"Exp Mol Med"},{"key":"11290_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/pathophysiology32030036","author":"A Kuliyeva","year":"2025","unstructured":"Kuliyeva A et al (2025) Post-COVID-19 femoral head osteonecrosis exhibits mast cell clusters, fibrosis, and vascular thrombosis: key pathological mechanisms in long COVID-19 bone degeneration. Pathophysiology. https:\/\/doi.org\/10.3390\/pathophysiology32030036","journal-title":"Pathophysiology"},{"issue":"11","key":"11290_CR51","first-page":"3508","volume":"10","author":"T Tian","year":"2020","unstructured":"Tian T et al (2020) The protective role of short-chain fatty acids acting as signal molecules in chemotherapy- or radiation-induced intestinal inflammation. Am J Cancer Res 10(11):3508\u20133531","journal-title":"Am J Cancer Res"},{"key":"11290_CR52","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2025.5687","author":"J Wang","year":"2026","unstructured":"Wang J et al (2026) Microbial short chain fatty acids: effective histone deacetylase inhibitors in immune regulation (review). Int J Mol Med. https:\/\/doi.org\/10.3892\/ijmm.2025.5687","journal-title":"Int J Mol Med"},{"issue":"1","key":"11290_CR53","volume":"16","author":"S Nie","year":"2024","unstructured":"Nie S et al (2024) CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA. Gut Microbes 16(1):2379633","journal-title":"Gut Microbes"},{"issue":"10","key":"11290_CR54","volume":"24","author":"Y Yao","year":"2025","unstructured":"Yao Y et al (2025) Intersection of immune signaling and cell death: the bidirectional regulatory mechanism of STING pathway and ferroptosis. Autoimmun Rev 24(10):103877","journal-title":"Autoimmun Rev"},{"key":"11290_CR55","doi-asserted-by":"crossref","first-page":"1710457","DOI":"10.3389\/fonc.2026.1710457","volume":"16","author":"F Lai","year":"2026","unstructured":"Lai F et al (2026) Chemotherapy-induced gut microbiota dysbiosis exacerbates cancer-related fatigue in breast cancer patients via neuroimmune-endocrine indicators. Front Oncol 16:1710457","journal-title":"Front Oncol"},{"key":"11290_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105840","volume":"172","author":"K Socala","year":"2021","unstructured":"Socala K et al (2021) The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res 172:105840","journal-title":"Pharmacol Res"},{"key":"11290_CR57","volume":"13","author":"Z Lv","year":"2022","unstructured":"Lv Z et al (2022) Acupuncture ameliorates breast cancer-related fatigue by regulating the gut microbiota-gut-brain axis. Front Endocrinol (Lausanne) 13:921119","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11290_CR58","doi-asserted-by":"crossref","first-page":"1613132","DOI":"10.3389\/fnut.2025.1613132","volume":"12","author":"H Feng","year":"2025","unstructured":"Feng H et al (2025) Lycium barbarum-probiotic synergy alleviates chemotherapy-induced cancer-related fatigue via gut microbiota-metabolic axis regulation in mice. Front Nutr 12:1613132","journal-title":"Front Nutr"},{"key":"11290_CR59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108191","volume":"227","author":"R Chen","year":"2026","unstructured":"Chen R et al (2026) Chemotherapy-induced gastrointestinal dysfunction: mechanisms and integrative Western-Chinese medicine strategies. Pharmacol Res 227:108191","journal-title":"Pharmacol Res"},{"key":"11290_CR60","volume":"155","author":"Y Wang","year":"2026","unstructured":"Wang Y et al (2026) Current advances in restoring intestinal barrier homeostasis by natural medicines. Phytomedicine 155:158144","journal-title":"Phytomedicine"},{"key":"11290_CR61","volume":"16","author":"B Wang","year":"2025","unstructured":"Wang B et al (2025) Astragalus polysaccharides: structure-immunomodulation relationships, multi-target pharmacological activities, and cutting-edge applications in immune modulation. Front Immunol 16:1714898","journal-title":"Front Immunol"},{"issue":"Pt 1","key":"11290_CR62","volume":"316","author":"Y Qin","year":"2025","unstructured":"Qin Y et al (2025) Integrative multi-omics reveals the protective function and molecular weight components of Astragalus polysaccharide against chemotherapeutic intestinal mucositis in Drosophila and mice. Int J Biol Macromol 316(Pt 1):144748","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"11290_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41538-025-00416-9","volume":"9","author":"X Zhou","year":"2025","unstructured":"Zhou X et al (2025) Regulatory effects of Poria cocos polysaccharides on gut microbiota and metabolites: evaluation of prebiotic potential. NPJ Sci Food 9(1):53","journal-title":"NPJ Sci Food"},{"issue":"6","key":"11290_CR64","volume":"20","author":"W Li","year":"2025","unstructured":"Li W et al (2025) Protection of LPS-induced intestinal injury in goslings by polysaccharide of Atractylodes macrocephala Koidz based on 16S rRNA and metabolomics analysis. PLoS ONE 20(6):e0326164","journal-title":"PLoS ONE"},{"key":"11290_CR65","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijbiomac.2021.12.042","volume":"195","author":"L Kai","year":"2022","unstructured":"Kai L et al (2022) Protective effects of polysaccharides from Atractylodes macrocephalae Koidz. against dextran sulfate sodium induced intestinal mucosal injury on mice. Int J Biol Macromol 195:142\u2013151","journal-title":"Int J Biol Macromol"},{"issue":"Pt 3","key":"11290_CR66","volume":"310","author":"R Wu","year":"2025","unstructured":"Wu R et al (2025) Protective effects of jiawei yupingfeng polysaccharides on cyclophosphamide-induced intestinal injury in mice. Int J Biol Macromol 310(Pt 3):143405","journal-title":"Int J Biol Macromol"},{"issue":"Pt 4","key":"11290_CR67","volume":"253","author":"Z He","year":"2023","unstructured":"He Z et al (2023) Atractylodes macrocephala Koidz polysaccharide improves glycolipid metabolism disorders through activation of aryl hydrocarbon receptor by gut flora-produced tryptophan metabolites. Int J Biol Macromol 253(Pt 4):126987","journal-title":"Int J Biol Macromol"},{"key":"11290_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13163934","author":"RK Al-Ishaq","year":"2021","unstructured":"Al-Ishaq RK et al (2021) Enzymatic metabolism of flavonoids by gut microbiota and its impact on gastrointestinal cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13163934","journal-title":"Cancers (Basel)"},{"issue":"11","key":"11290_CR69","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1007\/s10787-025-01932-6","volume":"33","author":"B Ghorbani-Nejad","year":"2025","unstructured":"Ghorbani-Nejad B et al (2025) Curcumin: multifaceted biological actions and therapeutic implications-a narrative review. Inflammopharmacology 33(11):6309\u20136327","journal-title":"Inflammopharmacology"},{"issue":"1","key":"11290_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12898-z","volume":"24","author":"W Deng","year":"2024","unstructured":"Deng W et al (2024) Curcumin suppresses colorectal tumorigenesis through restoring the gut microbiota and metabolites. BMC Cancer 24(1):1141","journal-title":"BMC Cancer"},{"issue":"6","key":"11290_CR71","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.joim.2024.09.003","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X et al (2024) A comprehensive overview on antiviral effects of baicalein and its glucuronide derivative baicalin. J Integr Med 22(6):621\u2013636","journal-title":"J Integr Med"},{"issue":"2","key":"11290_CR72","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1007\/s00210-025-04523-y","volume":"399","author":"C Xu","year":"2026","unstructured":"Xu C et al (2026) Baicalin: bridging traditional medicine and modern science in food and functional applications. Naunyn Schmiedebergs Arch Pharmacol 399(2):1917\u20131949","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"12","key":"11290_CR73","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1007\/s00253-020-10527-w","volume":"104","author":"L Zhu","year":"2020","unstructured":"Zhu L et al (2020) Protective effect of baicalin on the regulation of Treg\/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis. Appl Microbiol Biotechnol 104(12):5449\u20135460","journal-title":"Appl Microbiol Biotechnol"},{"key":"11290_CR74","volume":"283","author":"J Li","year":"2024","unstructured":"Li J et al (2024) Baicalin ameliorates heat stress-induced hepatic injury and intestinal microecology dysbiosis in late gestational mice. Ecotoxicol Environ Saf 283:116832","journal-title":"Ecotoxicol Environ Saf"},{"key":"11290_CR75","unstructured":"Meng Bowen, H.C., Effects of the Jianpi Xiezhuo method on gut microbiota and clinical efficacy in patients with gout. Rheumatism and Arthritis, 2021(10(2):1\u20134)."},{"issue":"1","key":"11290_CR76","first-page":"42","volume":"16","author":"W Su","year":"2024","unstructured":"Su W et al (2024) Potential efficacy and mechanism of eight mild-natured and bitter-flavored TCMs based on gut microbiota: a review. Chin Herb Med 16(1):42\u201355","journal-title":"Chin Herb Med"},{"issue":"1","key":"11290_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2021.1897212","volume":"13","author":"A Nogal","year":"2021","unstructured":"Nogal A, Valdes AM, Menni C (2021) The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health. Gut Microbes 13(1):1\u201324","journal-title":"Gut Microbes"},{"issue":"2","key":"11290_CR78","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2024.101961","volume":"38","author":"A Furst","year":"2024","unstructured":"Furst A, Gill T (2024) Exploring the role of gut microbes in spondyloarthritis: implications for pathogenesis and therapeutic strategies. Best Pract Res Clin Rheumatol 38(2):101961","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"11290_CR79","volume":"13","author":"C Li","year":"2022","unstructured":"Li C, Liang Y, Qiao Y (2022) Messengers from the gut: gut microbiota-derived metabolites on host regulation. Front Microbiol 13:863407","journal-title":"Front Microbiol"},{"issue":"1","key":"11290_CR80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tem.2024.06.016","volume":"36","author":"P Song","year":"2025","unstructured":"Song P, Peng Z, Guo X (2025) Gut microbial metabolites in cancer therapy. Trends Endocrinol Metab 36(1):55\u201369","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"11290_CR81","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/HYPERTENSIONAHA.122.18558","volume":"79","author":"J Xu","year":"2022","unstructured":"Xu J, Moore BN, Pluznick JL (2022) Short-chain fatty acid receptors and blood pressure regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021. Hypertension 79(10):2127\u20132137","journal-title":"Hypertension"},{"key":"11290_CR82","volume":"175","author":"D Lee","year":"2024","unstructured":"Lee D, Kim M, Han J (2024) GPR41 and GPR43: from development to metabolic regulation. Biomed Pharmacother 175:116735","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"11290_CR83","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood.2021010719","volume":"139","author":"MD Docampo","year":"2022","unstructured":"Docampo MD et al (2022) Alloreactive T cells deficient of the short-chain fatty acid receptor GPR109A induce less graft-versus-host disease. Blood 139(15):2392\u20132405","journal-title":"Blood"},{"key":"11290_CR84","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2018.05.003","volume":"831","author":"M Li","year":"2018","unstructured":"Li M et al (2018) Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. Eur J Pharmacol 831:52\u201359","journal-title":"Eur J Pharmacol"},{"key":"11290_CR85","doi-asserted-by":"crossref","unstructured":"Liu, T., et al., Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-kappaB pathway in RAW264.7 cells. Inflammation, 2012. 35(5): p. 1676\u201384.","DOI":"10.1007\/s10753-012-9484-z"},{"issue":"1","key":"11290_CR86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40813-023-00316-y","volume":"9","author":"M Andrani","year":"2023","unstructured":"Andrani M et al (2023) Acetate and propionate effects in response to LPS in a porcine intestinal co-culture model. Porcine Health Manag 9(1):23","journal-title":"Porcine Health Manag"},{"issue":"1","key":"11290_CR87","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41598-025-30385-8","volume":"16","author":"SM Cheatham","year":"2025","unstructured":"Cheatham SM et al (2025) Butyrate prevents chemotherapy-induced gastrointestinal toxicity and microbial dysbiosis. Sci Rep 16(1):785","journal-title":"Sci Rep"},{"issue":"22","key":"11290_CR88","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1111\/febs.70289","volume":"292","author":"D Parada-Venegas","year":"2025","unstructured":"Parada-Venegas D et al (2025) Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophages. FEBS J 292(22):6134\u20136157","journal-title":"FEBS J"},{"key":"11290_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234196","author":"N Kim","year":"2024","unstructured":"Kim N, Yang C (2024) Butyrate as a potential modulator in gynecological disease progression. Nutrients. https:\/\/doi.org\/10.3390\/nu16234196","journal-title":"Nutrients"},{"key":"11290_CR90","volume":"13","author":"J Li","year":"2026","unstructured":"Li J et al (2026) The immunoregulatory effect of short-chain fatty acids in type 2 diabetes mellitus. Front Nutr 13:1807302","journal-title":"Front Nutr"},{"key":"11290_CR91","doi-asserted-by":"crossref","first-page":"1337078","DOI":"10.3389\/fmicb.2024.1337078","volume":"15","author":"Q Liu","year":"2024","unstructured":"Liu Q et al (2024) Effects of Liqi Tongbian decoction on gut microbiota, SCFAs production, and 5-HT pathway in STC rats with Qi Stagnation Pattern. Front Microbiol 15:1337078","journal-title":"Front Microbiol"},{"key":"11290_CR92","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117332","volume":"271","author":"J Wanli","year":"2026","unstructured":"Wanli J et al (2026) Banxia Xiexin decoction modulates short-chain fatty acid metabolism and mitigates ulcerative colitis by reshaping the intestinal microbiota. J Pharm Biomed Anal 271:117332","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"11290_CR93","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13020-024-01019-4","volume":"19","author":"M Huang","year":"2024","unstructured":"Huang M et al (2024) Shen-Bai-Jie-Du decoction suppresses the progression of colorectal adenoma to carcinoma through regulating gut microbiota and short-chain fatty acids. Chin Med 19(1):149","journal-title":"Chin Med"},{"key":"11290_CR94","volume":"187","author":"P Huang","year":"2025","unstructured":"Huang P et al (2025) Digestion characteristics of Changyanning formula and its regulatory effect on fecal microbiota and metabolites during in vitro fermentation. Fitoterapia 187:106949","journal-title":"Fitoterapia"},{"issue":"9","key":"11290_CR95","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13205-024-04045-z","volume":"14","author":"B Qiao","year":"2024","unstructured":"Qiao B et al (2024) Shenling Baizhu powder attenuates lard diet in a fatigued state-induced diarrhea via targeting microbial metabolites short chain fatty acids-mediated lipid metabolism. 3 Biotech 14(9):203","journal-title":"3 Biotech"},{"issue":"1","key":"11290_CR96","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev-biochem-032620-104707","volume":"94","author":"CB Moffatt","year":"2025","unstructured":"Moffatt CB et al (2025) Inhibiting lipopolysaccharide biogenesis: the more you know the further you go. Annu Rev Biochem 94(1):137\u2013160","journal-title":"Annu Rev Biochem"},{"issue":"30","key":"11290_CR97","doi-asserted-by":"crossref","first-page":"26470","DOI":"10.1074\/jbc.M111.227934","volume":"286","author":"Q Liang","year":"2011","unstructured":"Liang Q et al (2011) Characterization of sparstolonin B, a Chinese herb-derived compound, as a selective Toll-like receptor antagonist with potent anti-inflammatory properties. J Biol Chem 286(30):26470\u201326479","journal-title":"J Biol Chem"},{"key":"11290_CR98","volume":"323","author":"B Zhang","year":"2024","unstructured":"Zhang B et al (2024) Study on anti-inflammatory effect of Shangkehuangshui in vitro and in vivo based on TLR4\/TLR2-NF-kappaB signaling pathway. J Ethnopharmacol 323:117709","journal-title":"J Ethnopharmacol"},{"key":"11290_CR99","volume":"17","author":"W Li","year":"2026","unstructured":"Li W et al (2026) Traditional Chinese medicine in the treatment of diabetic kidney disease: the mechanisms of signaling pathways regulations. Front Endocrinol (Lausanne) 17:1792000","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11290_CR100","doi-asserted-by":"crossref","first-page":"1285550","DOI":"10.3389\/fimmu.2023.1285550","volume":"14","author":"S Tang","year":"2023","unstructured":"Tang S et al (2023) Qinhuo Shanggan oral solution resolves acute lung injury by down-regulating TLR4\/NF-kappaB signaling cascade and inhibiting NLRP3 inflammasome activation. Front Immunol 14:1285550","journal-title":"Front Immunol"},{"key":"11290_CR101","first-page":"3051797","volume":"2022","author":"Y Ma","year":"2022","unstructured":"Ma Y et al (2022) A probe into the intervention mechanism of Yiqi Huayu Jiedu Decoction on TLR4\/NLRP3 signal pathway in lipopolysaccharide-induced acute respiratory distress syndrome (ARDS) rats. Evid Based Complement Alternat Med 2022:3051797","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"11290_CR102","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12906-023-04013-9","volume":"23","author":"Y Cui","year":"2023","unstructured":"Cui Y et al (2023) Effects of Si-Miao-Yong-An decoction on myocardial I\/R rats by regulating gut microbiota to inhibit LPS-induced TLR4\/NF-kappaB signaling pathway. BMC Complement Med Ther 23(1):180","journal-title":"BMC Complement Med Ther"},{"key":"11290_CR103","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jep.2019.02.040","volume":"237","author":"C Zhang","year":"2019","unstructured":"Zhang C et al (2019) The anti-diabetic activities, gut microbiota composition, the anti-inflammatory effects of Scutellaria-coptis herb couple against insulin resistance-model of diabetes involving the toll-like receptor 4 signaling pathway. J Ethnopharmacol 237:202\u2013214","journal-title":"J Ethnopharmacol"},{"key":"11290_CR104","unstructured":"Wu, H., et al., Efficacy of modified Yiwei Shengyang decoction in combination with FOLFOX4 chemotherapy for advanced gastric cancer. Altern Ther Health Med, 2024."},{"issue":"7","key":"11290_CR105","volume":"17","author":"H Ma","year":"2025","unstructured":"Ma H et al (2025) Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer. World J Gastrointest Surg 17(7):106487","journal-title":"World J Gastrointest Surg"},{"issue":"8","key":"11290_CR106","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.62347\/SRHB1100","volume":"16","author":"M Zhang","year":"2024","unstructured":"Zhang M et al (2024) Effects of Yipi Huayu decoction on tumor markers, immune function, and adverse reactions during chemotherapy in gastric cancer patients: a retrospective propensity score-matched study. Am J Transl Res 16(8):3599\u20133613","journal-title":"Am J Transl Res"},{"key":"11290_CR107","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/2135924","author":"M Wang","year":"2021","unstructured":"Wang M et al (2021) Effect of combining early chemotherapy with Zhipu Liujunzi decoction under the concept of strengthening and consolidating body resistance for gastric cancer patients and nursing strategy. Contrast Media Mol Imaging. https:\/\/doi.org\/10.1155\/2021\/2135924","journal-title":"Contrast Media Mol Imaging"},{"key":"11290_CR108","volume":"22","author":"J Xu","year":"2023","unstructured":"Xu J et al (2023) Shenqi Fuzheng injection combined with chemotherapy for gastric cancer: an overview of systematic reviews and meta-analyses. Integr Cancer Ther 22:15347354231210811","journal-title":"Integr Cancer Ther"},{"issue":"4","key":"11290_CR109","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7150\/jca.91301","volume":"15","author":"Z Bu","year":"2024","unstructured":"Bu Z et al (2024) Effectiveness and safety of Chinese herbal injections combined with SOX chemotherapy regimens for advanced gastric cancer: a Bayesian network meta-analysis. J Cancer 15(4):889\u2013907","journal-title":"J Cancer"},{"key":"11290_CR110","volume":"16","author":"B Pan","year":"2025","unstructured":"Pan B et al (2025) Efficacy and safety of commercial Chinese polyherbal preparation combined with oxaliplatin-based chemotherapy for gastric cancer: a systematic review and network meta-analysis. Front Pharmacol 16:1645079","journal-title":"Front Pharmacol"},{"issue":"1","key":"11290_CR111","volume":"17","author":"X Shi","year":"2025","unstructured":"Shi X et al (2025) Effects of Shenqi Xiangyi granules in advanced gastric cancer chemotherapy. World J Gastrointest Oncol 17(1):99272","journal-title":"World J Gastrointest Oncol"},{"issue":"8","key":"11290_CR112","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s00520-024-08740-8","volume":"32","author":"C Yu","year":"2024","unstructured":"Yu C, Mao X, Zhou C (2024) Influence of acupuncture and moxibustion on gastrointestinal function and adverse events in gastric cancer patients after surgery and chemotherapy: a meta-analysis. Support Care Cancer 32(8):524","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11290-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11290-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11290-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:48:31Z","timestamp":1792086511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11290-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":112,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["11290"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11290-w","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1041"}}